Table 2 Adherence to SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) reporting guidelines in randomised clinical trials that received ethical Approval in 2012 and 2016, respectively
2012 | 2016 | |||||
|---|---|---|---|---|---|---|
Industry sponsorship (n=49) | Non-industry sponsorship (n=54) | Total 2012 (n=103) | Industry sponsorship (n=62) | Non-industry sponsorship (n=46) | Total 2016 (n=108) | |
SPIRIT items (n=33) adequately reported (median; IQR)a | 22.5 (20.8–22.9) | 19.8 (15.3–22.3) | 21.4 (19.0–22.8) | 25.0 (23.5–26.1) | 21.5 (17.0–25.2) | 23.9 (21.6–25.8) |
Proportion of SPIRIT items adequately reported (median; IQR) | 67.4% (64.1–69.4%) | 59.8% (46.5–67.7%) | 64.9% (57.6–69.2%) | 75.6% (71.2–79.0%) | 65.3% (51.6–76.3%) | 72.5% (65.3–78.3%) |